ArticleCureus2025
Maternal Vaccination Coverage in Brazil From 2018 to 2022: A Cross-Sectional Descriptive Analysis Using Minimum and Maximum Estimates.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrazil has historically achieved high immunization coverage through its National Immunization Program (PNI). Vaccination during pregnancy is essential to protect both mothers and infants, yet routine immunization services were disrupted during the COVID-19 pandemic. Monitoring maternal vaccination coverage is crucial to inform public health strategies.
methodsThis cross-sectional descriptive study analyzed publicly available data from the Department of Information and Informatics of the Unified Health System (DATASUS) for 2018-2022. Pregnant women aged 18-49 years were included. Vaccination coverage was estimated using two scenarios: minimum coverage (two doses: influenza and Tdap (tetanus, diphtheria, and acellular pertussis)) and maximum coverage (five doses: influenza, Tdap, and three doses of hepatitis B). Coverage was calculated as the ratio of doses administered to expected doses, using live births as the denominator.
resultsMinimum coverage increased in all regions, ranging from 35.7-43.0% in 2018 to 44.5-86.6% in 2022. Maximum coverage ranged from 14.3-17.2% in 2018 to 17.8-34.6% in 2022. The North region showed the largest relative gain in minimum coverage (+43.4 percentage points), while the South and Southeast regions experienced temporary declines in 2021 compared to 2020 (-12 to -13 points), followed by a recovery in 2022.
conclusionsMaternal vaccination coverage in Brazil demonstrated resilience after the initial decline during the COVID-19 pandemic, with minimum coverage exceeding 70% in the North, Northeast, and Midwest regions by 2020, while the South and Southeast regions remained below this threshold. Regional heterogeneity, particularly lower recovery in the Southeast, highlights the need for tailored strategies to sustain and expand maternal immunization. These findings provide evidence to guide public health interventions and reinforce the importance of continuous monitoring of maternal vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.